Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?Brian Godman, William Shrank, Bjorn Wettermark, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2010
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implicationsBrian Godman, William Shrank, Morten Andersen, et al.
Frontiers in Pharmacology|August 12, 2011
Policies to enhance prescribing efficiency in europe: findings and future implicationsBrian Godman, William Shrank, Morten Andersen, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Frontiers in Pharmacology|June 25, 2014
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Expert Review of Clinical Pharmacology|December 10, 2014
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Frontiers in Pharmacology|August 13, 2016
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureWinnie de Bruijn, Cristina Ibáñez, Pia Frisk, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
Pageof 3